 |
|
FURTHER OBSERVATIONS ON THE USE OF TRIETHYLENE MELAMINE IN NEOPLASTIC DISEASES
JANE C. WRIGHT, M.D.;
AARON PRIGOT, M.D.;
LOUIS T. WRIGHT, M.D.;
ISIDORE ARONS, M.D.
AMA Arch Intern Med. 1952;89(3):387-404.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
IN A PREVIOUS paper1 we reported that triethylene melamine, a substance which was developed for the crease-proofing of cloth, and which showed growthinhibitory properties in tumors in animals, had beneficial effects in the treatment of 14 human beings suffering from lymphosarcoma, Hodgkin's disease, chronic myelogenous leukemia, fibrosarcoma, reticulum-cell sarcoma, and mycosis fungoides. We observed during that investigation no improvement in patients with anaplastic sarcoma, osteogenic sarcoma, and carcinoma. These findings have been substantially confirmed by the report of Karnofsky and associates.2
PRESENT STUDY
At this time we wish to report on the use of this chemotherapeutic agent in the treatment of an additional 28 adults with neoplastic diseases, and follow-up observations on 6 previously reported patients, who were still under study at the time of publication. Table 1 shows the classification and number of patients having each type of disease treated in the present and in the previously
. . . [Full Text PDF of this Article]
Author Affiliations
NEW YORK
From the Cancer Research Foundation, Harlem Hospital, Department of Hospitals, New York.
Footnotes
Read in part before the meeting of the American Association for Cancer Research, Cleveland, April 28, 1951. This investigation was supported in part by a research grant from the National Cancer Institute, of the National Institutes of Health, United States Public Health Service (C-629 C-2) and in part by the Damon Runyon Memorial Fund (DRIR-50-91).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
